Completed OBSERVATIONAL NCT00763100

Efficacy of Tomosynthesis in the BIRADS 3 Population (BIRADS)

The Efficacy of Tomosynthesis in the BIRADS 3 Population Including Surveillance of Patients in the Treatment or Post-Treatment for Breast Cancer

Sponsor: Hologic, Inc.

Conditions Breast Cancer

Updated 7 times since 2017 Last updated: Jan 5, 2011 Started: May 31, 2008 Primary completion: Nov 30, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00763100, this observational or N/A phase trial focuses on Breast Cancer and remains completed. Sponsored by Hologic, Inc., it has been updated 7 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hologic, Inc.
WellSpan Health

Data source: WellSpan Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.